Operating Lease, Right-of-Use Asset in USD of Bionik Laboratories Corp. from Q1 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Bionik Laboratories Corp. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2022 to Q1 2023.
  • Bionik Laboratories Corp. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2023 was $255K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)

Bionik Laboratories Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2023 $255K +$255K 31 Mar 2023 10-K 21 Jun 2023
Q4 2022 $260K 31 Dec 2022 10-Q 08 Feb 2023
Q3 2022 $265K 30 Sep 2022 10-Q 09 Nov 2022
Q1 2022 $0 31 Mar 2022 10-K 21 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.